drug

Active iTBS

active iTBS
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Central South University
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Investigational (via trials)
SchizophreniaSchizophreniaBody Weight

Trials

2
iTBS for Increased Appetite Induced by Antipsychotics
NCT05783063—Recruiting
Intermittent Theta Burst Stimulation (iTBS) for the Treatment of Negative Symptoms in Schizophrenia
NCT00875498—Completed

KOLs & investigators

3
Renrong Wu, M.D., Ph.D.KOL score 5
jerome brunelin, PhDKOL score 0
Emmanuel Poulet, MD, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Central South University
company
trial
iTBS for Increased Appetite Induced by Antipsychotics
NA
trial
Intermittent Theta Burst Stimulation (iTBS) for the Treatment of Negative Symptoms in Schizophrenia
NA
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Body Weight
indication
KOL
Renrong Wu, M.D., Ph.D.
KOL score 5
person
jerome brunelin, PhD
KOL score 0
person
Emmanuel Poulet, MD, PhD
KOL score —
person